1. Home
  2. KC vs NAMS Comparison

KC vs NAMS Comparison

Compare KC & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KC
  • NAMS
  • Stock Information
  • Founded
  • KC 2012
  • NAMS 2019
  • Country
  • KC China
  • NAMS Netherlands
  • Employees
  • KC N/A
  • NAMS N/A
  • Industry
  • KC Computer Software: Prepackaged Software
  • NAMS Biotechnology: Pharmaceutical Preparations
  • Sector
  • KC Technology
  • NAMS Health Care
  • Exchange
  • KC Nasdaq
  • NAMS Nasdaq
  • Market Cap
  • KC 1.9B
  • NAMS 1.7B
  • IPO Year
  • KC 2020
  • NAMS N/A
  • Fundamental
  • Price
  • KC $9.58
  • NAMS $25.50
  • Analyst Decision
  • KC Strong Buy
  • NAMS Strong Buy
  • Analyst Count
  • KC 7
  • NAMS 6
  • Target Price
  • KC $5.69
  • NAMS $36.20
  • AVG Volume (30 Days)
  • KC 3.9M
  • NAMS 1.4M
  • Earning Date
  • KC 11-19-2024
  • NAMS 02-06-2025
  • Dividend Yield
  • KC N/A
  • NAMS N/A
  • EPS Growth
  • KC N/A
  • NAMS N/A
  • EPS
  • KC N/A
  • NAMS N/A
  • Revenue
  • KC $1,037,206,927.00
  • NAMS $33,594,000.00
  • Revenue This Year
  • KC $11.27
  • NAMS $129.49
  • Revenue Next Year
  • KC $11.96
  • NAMS N/A
  • P/E Ratio
  • KC N/A
  • NAMS N/A
  • Revenue Growth
  • KC N/A
  • NAMS 78.77
  • 52 Week Low
  • KC $2.02
  • NAMS $10.50
  • 52 Week High
  • KC $9.77
  • NAMS $27.29
  • Technical
  • Relative Strength Index (RSI)
  • KC 67.82
  • NAMS 62.30
  • Support Level
  • KC $8.14
  • NAMS $24.40
  • Resistance Level
  • KC $8.73
  • NAMS $26.95
  • Average True Range (ATR)
  • KC 0.54
  • NAMS 1.66
  • MACD
  • KC -0.12
  • NAMS 0.41
  • Stochastic Oscillator
  • KC 92.66
  • NAMS 81.51

About KC Kingsoft Cloud Holdings Limited

Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Safety, database, AI, hybrid cloud and others. Its solutions are medical, government affairs, finance, media, Educate, game, Transportation and Logistics, Audio, and video.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: